High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT00131027 · UNKNOWN

Trial details

NCT number: NCT00131027
Sponsor: Japan Adult Leukemia Study Group
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute

Start date: 2002-09-01
Primary completion: 2011-03-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.